Carson Wealth (CWM LLC)’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $42.6K | Buy |
2,535
+19
| +0.8% | +$340 | ﹤0.01% | 3925 |
|
|
2025
Q4 | $40K | Buy |
2,516
+668
| +36% | +$9.94K | ﹤0.01% | 3759 |
|
|
2025
Q3 | $23K | Buy |
1,848
+1,351
| +272% | +$15.8K | ﹤0.01% | 4031 |
|
|
2025
Q2 | $6K | Sell |
497
-1,561
| -76% | -$18.5K | ﹤0.01% | 4524 |
|
|
2025
Q1 | $31K | Sell |
2,058
-1,754
| -46% | -$29.4K | ﹤0.01% | 3356 |
|
|
2024
Q4 | $66K | Buy |
3,812
+102
| +3% | +$1.97K | ﹤0.01% | 2582 |
|
|
2024
Q3 | $69K | Buy |
3,710
+61
| +2% | +$1.23K | ﹤0.01% | 2446 |
|
|
2024
Q2 | $74K | Buy |
3,649
+69
| +2% | +$1.22K | ﹤0.01% | 2189 |
|
|
2024
Q1 | $61K | Buy |
3,580
+3,300
| +1,179% | +$51.9K | ﹤0.01% | 2167 |
|
|
2023
Q4 | $5K | Sell |
280
-153
| -35% | -$3.08K | ﹤0.01% | 3488 |
|
|
2023
Q3 | $10K | Buy |
433
+15
| +4% | +$368 | ﹤0.01% | 3121 |
|
|
2023
Q2 | $10K | Buy |
418
+30
| +8% | +$678 | ﹤0.01% | 3065 |
|
|
2023
Q1 | $9K | Buy |
388
+215
| +124% | +$5.03K | ﹤0.01% | 2995 |
|
|
2022
Q4 | $4K | Buy |
173
+144
| +497% | +$2.79K | ﹤0.01% | 3273 |
|
|
2022
Q3 | $0 | Sell |
29
-96
| -77% | -$1.62K | ﹤0.01% | 3942 |
|
|
2022
Q2 | $2K | Buy |
+125
| New | +$3.32K | ﹤0.01% | 3310 |
|
|
2021
Q2 | $3K | Hold |
77
| – | – | ﹤0.01% | 2505 |
|
|
2021
Q1 | $3K | Hold |
77
| – | – | ﹤0.01% | 2505 |
|
|
2020
Q4 | $3K | Hold |
77
| – | – | ﹤0.01% | 2505 |
|
|
2020
Q3 | $3K | Hold |
77
| – | – | ﹤0.01% | 2505 |
|
|
2020
Q2 | $3K | Hold |
77
| – | – | ﹤0.01% | 2504 |
|
|
2020
Q1 | $3K | Hold |
77
| – | – | ﹤0.01% | 2504 |
|
|
2019
Q4 | $3K | Hold |
77
| – | – | ﹤0.01% | 2504 |
|
|
2019
Q3 | $3K | Hold |
77
| – | – | ﹤0.01% | 2504 |
|
|
2019
Q2 | $3K | Hold |
77
| – | – | ﹤0.01% | 2504 |
|
|
2019
Q1 | $3K | Buy |
77
+28
| +57% | +$1.88K | ﹤0.01% | 2504 |
|
|
2018
Q4 | $3K | Buy |
49
+4
| +9% | +$345 | ﹤0.01% | 1647 |
|
|
2018
Q3 | $5K | Buy |
45
+18
| +67% | +$2.03K | ﹤0.01% | 1334 |
|
|
2018
Q2 | $3K | Hold |
27
| – | – | ﹤0.01% | 1281 |
|
|
2018
Q1 | $3K | Hold |
27
| – | – | ﹤0.01% | 1085 |
|
|
2017
Q4 | $3K | Hold |
27
| – | – | ﹤0.01% | 1185 |
|
|
2017
Q3 | $3K | Hold |
27
| – | – | ﹤0.01% | 1189 |
|
|
2017
Q2 | $3K | Hold |
27
| – | – | ﹤0.01% | 947 |
|
|
2017
Q1 | $3K | Hold |
27
| – | – | ﹤0.01% | 927 |
|
|
2016
Q4 | $3K | Hold |
27
| – | – | ﹤0.01% | 912 |
|
|
2016
Q3 | $3K | Sell |
27
-6
| -18% | -$691 | ﹤0.01% | 871 |
|
|
2016
Q2 | $4K | Sell |
33
-4,222
| -99% | -$510K | ﹤0.01% | 651 |
|
|
2016
Q1 | $478K | Buy |
4,255
+1,289
| +43% | +$134K | 0.04% | 188 |
|
|
2015
Q4 | $323K | Buy |
2,966
+827
| +39% | +$94.7K | 0.03% | 196 |
|
|
2015
Q3 | $213K | Buy |
2,139
+263
| +14% | +$28.6K | 0.02% | 201 |
|
|
2015
Q2 | $214K | Sell |
1,876
-18,283
| -91% | -$2.22M | 0.02% | 177 |
|
|
2015
Q1 | $2.11M | Buy |
20,159
+4,405
| +28% | +$469K | 0.21% | 124 |
|
|
2014
Q4 | $1.9M | Buy |
15,754
+3,767
| +31% | +$495K | 0.23% | 124 |
|
|
2014
Q3 | $1.75M | Buy |
11,987
+1,680
| +16% | +$259K | 0.25% | 104 |
|
|
2014
Q2 | $1.72M | Buy |
10,307
+2,966
| +40% | +$528K | 0.31% | 97 |
|
|
2014
Q1 | $1.46M | Buy |
7,341
+1,851
| +34% | +$349K | 0.2% | 81 |
|
|
2013
Q4 | $1.05M | Buy |
5,490
+1,352
| +33% | +$252K | 0.16% | 89 |
|
|
2013
Q3 | $700K | Buy |
+4,138
| New | +$642K | 0.18% | 67 |
|
Other funds holding CLB
AI
DGI
CAMG
Carson Wealth (CWM LLC)'s CLB Position: Q1 2026 in Review
Carson Wealth (CWM LLC) increased its Core Laboratories (CLB) stake by 0.76% in Q1 2026, buying an estimated $340 and bringing the position to 2,535 shares worth $42.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3925.
Carson Wealth (CWM LLC) first reported a position in CLB in Q3 2013 and has held it in 48 quarters since. The position peaked at $2.11M in Q1 2015. 190 funds tracked by Wall St. Rank hold CLB as of Q1 2026.
- Carson Wealth (CWM LLC) held 2,535 shares of Core Laboratories worth $42.6K as of Q1 2026.
- Carson Wealth (CWM LLC) bought 19 Core Laboratories shares in Q1 2026, an estimated $340.
- Core Laboratories made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #3925 holding.
- Carson Wealth (CWM LLC) first reported a position in Core Laboratories in Q3 2013 and has held it in 48 quarters since.
- Carson Wealth (CWM LLC)'s Core Laboratories position peaked at $2.11M in Q1 2015.
- 190 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2026.
Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.